PDF herunterladen
CC BY-NC-ND 4.0 · Semin Liver Dis 2023; 43(01): 013-023
DOI: 10.1055/s-0042-1760306
Review Article

Update on Hepatobiliary Plasticity

Minwook Kim   *
1   Department of Developmental Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
,
Fatima Rizvi   *
2   Department of Medicine, Gastroenterology Section, Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, Massachusetts
,
Donghun Shin
1   Department of Developmental Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
,
Valerie Gouon-Evans
2   Department of Medicine, Gastroenterology Section, Center for Regenerative Medicine, Boston University and Boston Medical Center, Boston, Massachusetts
› Institutsangaben Funding This work was supported by the NIH/NIDDK awards R01DK133404 to V.G-E. and D.S. and R01DK101426 and R01DK132014 to D.S.
› Weitere Informationen
   Lizenzen und Reprints


Abstract

The liver field has been debating for decades the contribution of the plasticity of the two epithelial compartments in the liver, hepatocytes and biliary epithelial cells (BECs), to derive each other as a repair mechanism. The hepatobiliary plasticity has been first observed in diseased human livers by the presence of biphenotypic cells expressing hepatocyte and BEC markers within bile ducts and regenerative nodules or budding from strings of proliferative BECs in septa. These observations are not surprising as hepatocytes and BECs derive from a common fetal progenitor, the hepatoblast, and, as such, they are expected to compensate for each other's loss in adults. To investigate the cell origin of regenerated cell compartments and associated molecular mechanisms, numerous murine and zebrafish models with ability to trace cell fates have been extensively developed. This short review summarizes the clinical and preclinical studies illustrating the hepatobiliary plasticity and its potential therapeutic application.

Keywords

hepatocyte plasticity - cholangiocyte plasticity - biliary epithelial cell plasticity - liver progenitor cells - liver regeneration


Publikationsverlauf

Artikel online veröffentlicht:
10. Februar 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Miyajima A, Tanaka M, Itoh T. Stem/progenitor cells in liver development, homeostasis, regeneration, and reprogramming. Cell Stem Cell 2014; 14 (05) 561-574
    CrossrefPubMedGoogle Scholar
  • 2 Dorrell C, Erker L, Lanxon-Cookson KM. et al. Surface markers for the murine oval cell response. Hepatology 2008; 48 (04) 1282-1291
    CrossrefPubMedGoogle Scholar
  • 3 Jensen CH, Jauho EI, Santoni-Rugiu E. et al. Transit-amplifying ductular (oval) cells and their hepatocytic progeny are characterized by a novel and distinctive expression of delta-like protein/preadipocyte factor 1/fetal antigen 1. Am J Pathol 2004; 164 (04) 1347-1359
    CrossrefPubMedGoogle Scholar
  • 4 Kamiya A, Kakinuma S, Yamazaki Y, Nakauchi H. Enrichment and clonal culture of progenitor cells during mouse postnatal liver development in mice. Gastroenterology 2009; 137 (03) 1114-1126 , 1126.e1–1126.e14
    CrossrefPubMedGoogle Scholar
  • 5 Okabe M, Tsukahara Y, Tanaka M. et al. Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver. Development 2009; 136 (11) 1951-1960
    CrossrefPubMedGoogle Scholar
  • 6 Qiu Q, Hernandez JC, Dean AM, Rao PH, Darlington GJ. CD24-positive cells from normal adult mouse liver are hepatocyte progenitor cells. Stem Cells Dev 2011; 20 (12) 2177-2188
    CrossrefPubMedGoogle Scholar
  • 7 Rountree CB, Barsky L, Ge S, Zhu J, Senadheera S, Crooks GM. A CD133-expressing murine liver oval cell population with bilineage potential. Stem Cells 2007; 25 (10) 2419-2429
    CrossrefPubMedGoogle Scholar
  • 8 Schmelzer E, Zhang L, Bruce A. et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 2007; 204 (08) 1973-1987
    CrossrefPubMedGoogle Scholar
  • 9 Suzuki A, Sekiya S, Onishi M. et al. Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver. Hepatology 2008; 48 (06) 1964-1978
    CrossrefPubMedGoogle Scholar
  • 10 Tanaka M, Okabe M, Suzuki K. et al. Mouse hepatoblasts at distinct developmental stages are characterized by expression of EpCAM and DLK1: drastic change of EpCAM expression during liver development. Mech Dev 2009; 126 (8-9): 665-676
    CrossrefPubMedGoogle Scholar
  • 11 Yovchev MI, Grozdanov PN, Zhou H, Racherla H, Guha C, Dabeva MD. Identification of adult hepatic progenitor cells capable of repopulating injured rat liver. Hepatology 2008; 47 (02) 636-647
    CrossrefPubMedGoogle Scholar
  • 12 Overi D, Carpino G, Cardinale V. et al. Contribution of resident stem cells to liver and biliary tree regeneration in human diseases. Int J Mol Sci 2018; 19 (10) 19
    CrossrefPubMedGoogle Scholar
  • 13 Shin S, Kaestner KH. The origin, biology, and therapeutic potential of facultative adult hepatic progenitor cells. Curr Top Dev Biol 2014; 107: 269-292
    CrossrefPubMedGoogle Scholar
  • 14 Sato K, Marzioni M, Meng F, Francis H, Glaser S, Alpini G. Ductular reaction in liver diseases: pathological mechanisms and translational significances. Hepatology 2019; 69 (01) 420-430
    CrossrefPubMedGoogle Scholar
  • 15 Boulter L, Lu WY, Forbes SJ. Differentiation of progenitors in the liver: a matter of local choice. J Clin Invest 2013; 123 (05) 1867-1873
    CrossrefPubMedGoogle Scholar
  • 16 Gouw AS, Clouston AD, Theise ND. Ductular reactions in human liver: diversity at the interface. Hepatology 2011; 54 (05) 1853-1863
    CrossrefPubMedGoogle Scholar
  • 17 Roskams TA, Theise ND, Balabaud C. et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 2004; 39 (06) 1739-1745
    CrossrefPubMedGoogle Scholar
  • 18 Roskams T, Desmet V. Ductular reaction and its diagnostic significance. Semin Diagn Pathol 1998; 15 (04) 259-269
    PubMedGoogle Scholar
  • 19 Popper H, Kent G, Stein R. Ductular cell reaction in the liver in hepatic injury. J Mt Sinai Hosp N Y 1957; 24 (05) 551-556
    PubMedGoogle Scholar
  • 20 Turányi E, Dezsö K, Csomor J, Schaff Z, Paku S, Nagy P. Immunohistochemical classification of ductular reactions in human liver. Histopathology 2010; 57 (04) 607-614
    CrossrefPubMedGoogle Scholar
  • 21 Lowes KN, Brennan BA, Yeoh GC, Olynyk JK. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 1999; 154 (02) 537-541
    CrossrefPubMedGoogle Scholar
  • 22 Van Haele M, Snoeck J, Roskams T. Human liver regeneration: an etiology dependent process. Int J Mol Sci 2019; 20 (09) 20
    CrossrefPubMedGoogle Scholar
  • 23 Roskams TA, Libbrecht L, Desmet VJ. Progenitor cells in diseased human liver. Semin Liver Dis 2003; 23 (04) 385-396
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 24 Yoon SM, Gerasimidou D, Kuwahara R. et al. Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans. Hepatology 2011; 53 (03) 964-973
    CrossrefPubMedGoogle Scholar
  • 25 Stueck AE, Wanless IR. Hepatocyte buds derived from progenitor cells repopulate regions of parenchymal extinction in human cirrhosis. Hepatology 2015; 61 (05) 1696-1707
    CrossrefPubMedGoogle Scholar
  • 26 Hytiroglou P, Theise ND. Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al. Virchows Arch 2018; 473 (01) 15-22
    CrossrefPubMedGoogle Scholar
  • 27 Wanless IR, Nakashima E, Sherman M. Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med 2000; 124 (11) 1599-1607
    PubMedGoogle Scholar
  • 28 Falkowski O, An HJ, Ianus IA. et al. Regeneration of hepatocyte ‘buds’ in cirrhosis from intrabiliary stem cells. J Hepatol 2003; 39 (03) 357-364
    CrossrefPubMedGoogle Scholar
  • 29 Fleming KE, Wanless IR. Glutamine synthetase expression in activated hepatocyte progenitor cells and loss of hepatocellular expression in congestion and cirrhosis. Liver Int 2013; 33 (04) 525-534
    CrossrefPubMedGoogle Scholar
  • 30 Deng X, Zhang X, Li W. et al. Chronic liver injury induces conversion of biliary epithelial cells into hepatocytes. Cell Stem Cell 2018; 23 (01) 114-122 .e3
    CrossrefPubMedGoogle Scholar
  • 31 Haque S, Haruna Y, Saito K. et al. Identification of bipotential progenitor cells in human liver regeneration. Lab Invest 1996; 75 (05) 699-705
    PubMedGoogle Scholar
  • 32 Sancho-Bru P, Altamirano J, Rodrigo-Torres D. et al. Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis. Hepatology 2012; 55 (06) 1931-1941
    CrossrefPubMedGoogle Scholar
  • 33 Hadi R, Shin K, Reder N. et al. Utility of glutamine synthetase immunohistochemistry in identifying features of regressed cirrhosis. Mod Pathol 2020; 33 (03) 448-455
    CrossrefPubMedGoogle Scholar
  • 34 Lin WR, Lim SN, McDonald SA. et al. The histogenesis of regenerative nodules in human liver cirrhosis. Hepatology 2010; 51 (03) 1017-1026
    CrossrefPubMedGoogle Scholar
  • 35 Fellous TG, Islam S, Tadrous PJ. et al. Locating the stem cell niche and tracing hepatocyte lineages in human liver. Hepatology 2009; 49 (05) 1655-1663
    CrossrefPubMedGoogle Scholar
  • 36 Van Eyken P, Sciot R, Desmet VJ. A cytokeratin immunohistochemical study of cholestatic liver disease: evidence that hepatocytes can express ‘bile duct-type’ cytokeratins. Histopathology 1989; 15 (02) 125-135
    CrossrefPubMedGoogle Scholar
  • 37 Bellizzi AM, LeGallo RD, Boyd JC, Iezzoni JC. Hepatocyte cytokeratin 7 expression in chronic allograft rejection. Am J Clin Pathol 2011; 135 (02) 238-244
    CrossrefPubMedGoogle Scholar
  • 38 Ernst LM, Spinner NB, Piccoli DA, Mauger J, Russo P. Interlobular bile duct loss in pediatric cholestatic disease is associated with aberrant cytokeratin 7 expression by hepatocytes. Pediatr Dev Pathol 2007; 10 (05) 383-390
    CrossrefPubMedGoogle Scholar
  • 39 Goldstein NS, Soman A, Gordon SC. Portal tract eosinophils and hepatocyte cytokeratin 7 immunoreactivity helps distinguish early-stage, mildly active primary biliary cirrhosis and autoimmune hepatitis. Am J Clin Pathol 2001; 116 (06) 846-853
    CrossrefPubMedGoogle Scholar
  • 40 Quaglia A, Bhathal PS. Copper, copper-binding protein and cytokeratin 7 in biliary disorders. Histopathology 2017; 71 (06) 1006-1008
    CrossrefPubMedGoogle Scholar
  • 41 Sakellariou S, Michaelides C, Voulgaris T. et al. Keratin 7 expression in hepatic cholestatic diseases. Virchows Arch 2021; 479 (04) 815-824
    CrossrefPubMedGoogle Scholar
  • 42 Sjöblom N, Boyd S, Manninen A. et al. Chronic cholestasis detection by a novel tool: automated analysis of cytokeratin 7-stained liver specimens. Diagn Pathol 2021; 16 (01) 41
    CrossrefPubMedGoogle Scholar
  • 43 Fabris L, Cadamuro M, Guido M. et al. Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling. Am J Pathol 2007; 171 (02) 641-653
    CrossrefPubMedGoogle Scholar
  • 44 Carpino G, Cardinale V, Folseraas T. et al. Hepatic stem/progenitor cell activation differs between primary sclerosing and primary biliary cholangitis. Am J Pathol 2018; 188 (03) 627-639
    CrossrefPubMedGoogle Scholar
  • 45 Chatzipantelis P, Lazaris AC, Kafiri G. et al. Cytokeratin-7, cytokeratin-19, and c-Kit: immunoreaction during the evolution stages of primary biliary cirrhosis. Hepatol Res 2006; 36 (03) 182-187
    CrossrefPubMedGoogle Scholar
  • 46 Limaye PB, Alarcón G, Walls AL. et al. Expression of specific hepatocyte and cholangiocyte transcription factors in human liver disease and embryonic development. Lab Invest 2008; 88 (08) 865-872
    CrossrefPubMedGoogle Scholar
  • 47 Cazzagon N, Sarcognato S, Floreani A. et al. Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis. JHEP Rep 2021; 3 (03) 100286
    CrossrefPubMedGoogle Scholar
  • 48 Harada K, Furubo S, Ozaki S, Hiramatsu K, Sudo Y, Nakanuma Y. Increased expression of WAF1 in intrahepatic bile ducts in primary biliary cirrhosis relates to apoptosis. J Hepatol 2001; 34 (04) 500-506
    CrossrefPubMedGoogle Scholar
  • 49 Meadows V, Baiocchi L, Kundu D. et al. Biliary epithelial senescence in liver disease: there will be SASP. Front Mol Biosci 2021; 8: 803098
    CrossrefPubMedGoogle Scholar
  • 50 Sasaki M, Ikeda H, Yamaguchi J, Nakada S, Nakanuma Y. Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence. Hepatology 2008; 48 (01) 186-195
    CrossrefPubMedGoogle Scholar
  • 51 Tabibian JH, O'Hara SP, Splinter PL, Trussoni CE, LaRusso NF. Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis. Hepatology 2014; 59 (06) 2263-2275
    CrossrefPubMedGoogle Scholar
  • 52 Tabibian JH, Trussoni CE, O'Hara SP, Splinter PL, Heimbach JK, LaRusso NF. Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis. Lab Invest 2014; 94 (10) 1126-1133
    CrossrefPubMedGoogle Scholar
  • 53 Crosby HA, Hubscher SG, Joplin RE, Kelly DA, Strain AJ. Immunolocalization of OV-6, a putative progenitor cell marker in human fetal and diseased pediatric liver. Hepatology 1998; 28 (04) 980-985
    CrossrefPubMedGoogle Scholar
  • 54 Crosby HA, Hubscher S, Fabris L. et al. Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6. Am J Pathol 1998; 152 (03) 771-779
    PubMedGoogle Scholar
  • 55 Tarlow BD, Pelz C, Naugler WE. et al. Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes. Cell Stem Cell 2014; 15 (05) 605-618
    CrossrefPubMedGoogle Scholar
  • 56 Alison M, Golding M, Lalani EN, Nagy P, Thorgeirsson S, Sarraf C. Wholesale hepatocytic differentiation in the rat from ductular oval cells, the progeny of biliary stem cells. J Hepatol 1997; 26 (02) 343-352
    CrossrefPubMedGoogle Scholar
  • 57 Evarts RP, Nagy P, Nakatsukasa H, Marsden E, Thorgeirsson SS. In vivo differentiation of rat liver oval cells into hepatocytes. Cancer Res 1989; 49 (06) 1541-1547
    PubMedGoogle Scholar
  • 58 Li Q, Gong Y, Wang Y. et al. Sirt1 promotes the restoration of hepatic progenitor cell (HPC)-mediated liver fatty injury in NAFLD through activating the Wnt/β-catenin signal pathway. Front Nutr 2021; 8: 791861
    CrossrefPubMedGoogle Scholar
  • 59 Manco R, Clerbaux LA, Verhulst S. et al. Reactive cholangiocytes differentiate into proliferative hepatocytes with efficient DNA repair in mice with chronic liver injury. J Hepatol 2019; 70 (06) 1180-1191
    CrossrefPubMedGoogle Scholar
  • 60 Han X, Wang Y, Pu W. et al. Lineage tracing reveals the bipotency of SOX9+ hepatocytes during liver regeneration. Stem Cell Reports 2019; 12 (03) 624-638
    CrossrefPubMedGoogle Scholar
  • 61 Shin S, Upadhyay N, Greenbaum LE, Kaestner KH. Ablation of Foxl1-Cre-labeled hepatic progenitor cells and their descendants impairs recovery of mice from liver injury. Gastroenterology 2015; 148 (01) 192-202 .e3
    CrossrefPubMedGoogle Scholar
  • 62 Español-Suñer R, Carpentier R, Van Hul N. et al. Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. Gastroenterology 2012; 143 (06) 1564-1575 .e7
    CrossrefPubMedGoogle Scholar
  • 63 Shin S, Walton G, Aoki R. et al. Foxl1-Cre-marked adult hepatic progenitors have clonogenic and bilineage differentiation potential. Genes Dev 2011; 25 (11) 1185-1192
    CrossrefPubMedGoogle Scholar
  • 64 Malato Y, Naqvi S, Schürmann N. et al. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J Clin Invest 2011; 121 (12) 4850-4860
    CrossrefPubMedGoogle Scholar
  • 65 Dorrell C, Erker L, Schug J. et al. Prospective isolation of a bipotential clonogenic liver progenitor cell in adult mice. Genes Dev 2011; 25 (11) 1193-1203
    CrossrefPubMedGoogle Scholar
  • 66 Sackett SD, Li Z, Hurtt R. et al. Foxl1 is a marker of bipotential hepatic progenitor cells in mice. Hepatology 2009; 49 (03) 920-929
    CrossrefPubMedGoogle Scholar
  • 67 Lu WY, Bird TG, Boulter L. et al. Hepatic progenitor cells of biliary origin with liver repopulation capacity. Nat Cell Biol 2015; 17 (08) 971-983
    CrossrefPubMedGoogle Scholar
  • 68 Raven A, Lu WY, Man TY. et al. Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration. Nature 2017; 547 (7663): 350-354
    CrossrefPubMedGoogle Scholar
  • 69 Russell JO, Lu WY, Okabe H. et al. Hepatocyte-specific β-catenin deletion during severe liver injury provokes cholangiocytes to differentiate into hepatocytes. Hepatology 2019; 69 (02) 742-759
    CrossrefPubMedGoogle Scholar
  • 70 Wood MJ, Gadd VL, Powell LW, Ramm GA, Clouston AD. Ductular reaction in hereditary hemochromatosis: the link between hepatocyte senescence and fibrosis progression. Hepatology 2014; 59 (03) 848-857
    CrossrefPubMedGoogle Scholar
  • 71 Gadd VL, Skoien R, Powell EE. et al. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. Hepatology 2014; 59 (04) 1393-1405
    CrossrefPubMedGoogle Scholar
  • 72 Weng HL, Feng DC, Radaeva S. et al. IFN-γ inhibits liver progenitor cell proliferation in HBV-infected patients and in 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet-fed mice. J Hepatol 2013; 59 (04) 738-745
    CrossrefPubMedGoogle Scholar
  • 73 Richardson MM, Jonsson JR, Powell EE. et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology 2007; 133 (01) 80-90
    CrossrefPubMedGoogle Scholar
  • 74 Clouston AD, Powell EE, Walsh MJ, Richardson MM, Demetris AJ, Jonsson JR. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 2005; 41 (04) 809-818
    CrossrefPubMedGoogle Scholar
  • 75 Roskams T, Yang SQ, Koteish A. et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol 2003; 163 (04) 1301-1311
    CrossrefPubMedGoogle Scholar
  • 76 Minnis-Lyons SE, Ferreira-González S, Aleksieva N. et al. Notch-IGF1 signaling during liver regeneration drives biliary epithelial cell expansion and inhibits hepatocyte differentiation. Sci Signal 2021; 14 (688) 14
    PubMedGoogle Scholar
  • 77 Aloia L, McKie MA, Vernaz G. et al. Epigenetic remodelling licences adult cholangiocytes for organoid formation and liver regeneration. Nat Cell Biol 2019; 21 (11) 1321-1333
    CrossrefPubMedGoogle Scholar
  • 78 Rizvi F, Everton E, Smith AR. et al. Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA. Nat Commun 2021; 12 (01) 613
    CrossrefPubMedGoogle Scholar
  • 79 Ota N, Shiojiri N. Comparative study on a novel lobule structure of the zebrafish liver and that of the mammalian liver. Cell Tissue Res 2022; 388 (02) 287-299
    CrossrefPubMedGoogle Scholar
  • 80 Caviglia S, Unterweger IA, Gasiūnaitė A. et al. FRaeppli: a multispectral imaging toolbox for cell tracing and dense tissue analysis in zebrafish. Development 2022; 149 (16) 149
    CrossrefPubMedGoogle Scholar
  • 81 Zhao C, Lancman JJ, Yang Y. et al. Intrahepatic cholangiocyte regeneration from an Fgf-dependent extrahepatic progenitor niche in a zebrafish model of Alagille Syndrome. Hepatology 2022; 75 (03) 567-583
    CrossrefPubMedGoogle Scholar
  • 82 Wang J, Leng X, Wang G, Wan X, Cao H. The construction of intrahepatic cholangiocarcinoma model in zebrafish. Sci Rep 2017; 7 (01) 13419
    CrossrefPubMedGoogle Scholar
  • 83 Goessling W, Sadler KC. Zebrafish: an important tool for liver disease research. Gastroenterology 2015; 149 (06) 1361-1377
    CrossrefPubMedGoogle Scholar
  • 84 Evason KJ, Francisco MT, Juric V. et al. Identification of chemical inhibitors of β-catenin-driven liver tumorigenesis in zebrafish. PLoS Genet 2015; 11 (07) e1005305
    CrossrefPubMedGoogle Scholar
  • 85 Den Broeder MJ, Kopylova VA, Kamminga LM, Legler J. Zebrafish as a model to study the role of peroxisome proliferating-activated receptors in adipogenesis and obesity. PPAR Res 2015; 2015: 358029
    CrossrefPubMedGoogle Scholar
  • 86 Nguyen AT, Emelyanov A, Koh CH. et al. A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish. Dis Model Mech 2011; 4 (06) 801-813
    CrossrefPubMedGoogle Scholar
  • 87 Vogt A, Cholewinski A, Shen X. et al. Automated image-based phenotypic analysis in zebrafish embryos. Dev Dyn 2009; 238 (03) 656-663
    CrossrefPubMedGoogle Scholar
  • 88 Liu W, Chen JR, Hsu CH. et al. A zebrafish model of intrahepatic cholangiocarcinoma by dual expression of hepatitis B virus X and hepatitis C virus core protein in liver. Hepatology 2012; 56 (06) 2268-2276
    CrossrefPubMedGoogle Scholar
  • 89 Shwartz A, Goessling W, Yin C. Macrophages in zebrafish models of liver diseases. Front Immunol 2019; 10: 2840
    CrossrefPubMedGoogle Scholar
  • 90 Pham DH, Yin C. Zebrafish as a model to study cholestatic liver diseases. Methods Mol Biol 2019; 1981: 273-289
    CrossrefPubMedGoogle Scholar
  • 91 Huang M, Chang A, Choi M, Zhou D, Anania FA, Shin CH. Antagonistic interaction between Wnt and Notch activity modulates the regenerative capacity of a zebrafish fibrotic liver model. Hepatology 2014; 60 (05) 1753-1766
    CrossrefPubMedGoogle Scholar
  • 92 Ko S, Shin D. Chemical screening using a zebrafish model for liver progenitor cell-driven liver regeneration. Methods Mol Biol 2019; 1905: 83-90
    CrossrefPubMedGoogle Scholar
  • 93 Cox AG, Saunders DC, Kelsey Jr PB. et al. S-nitrosothiol signaling regulates liver development and improves outcome following toxic liver injury. Cell Rep 2014; 6 (01) 56-69
    CrossrefPubMedGoogle Scholar
  • 94 He JH, Guo SY, Zhu F. et al. A zebrafish phenotypic assay for assessing drug-induced hepatotoxicity. J Pharmacol Toxicol Methods 2013; 67 (01) 25-32
    CrossrefPubMedGoogle Scholar
  • 95 North TE, Babu IR, Vedder LM. et al. PGE2-regulated Wnt signaling and N-acetylcysteine are synergistically hepatoprotective in zebrafish acetaminophen injury. Proc Natl Acad Sci U S A 2010; 107 (40) 17315-17320
    CrossrefPubMedGoogle Scholar
  • 96 He J, Lu H, Zou Q, Luo L. Regeneration of liver after extreme hepatocyte loss occurs mainly via biliary transdifferentiation in zebrafish. Gastroenterology 2014; 146 (03) 789-800 .e8
    CrossrefPubMedGoogle Scholar
  • 97 Choi TY, Ninov N, Stainier DY, Shin D. Extensive conversion of hepatic biliary epithelial cells to hepatocytes after near total loss of hepatocytes in zebrafish. Gastroenterology 2014; 146 (03) 776-788
    CrossrefPubMedGoogle Scholar
  • 98 Ko S, Choi TY, Russell JO, So J, Monga SPS, Shin D. Bromodomain and extraterminal (BET) proteins regulate biliary-driven liver regeneration. J Hepatol 2016; 64 (02) 316-325
    CrossrefPubMedGoogle Scholar
  • 99 He J, Zhou Y, Qian C. et al. DNA methylation maintenance at the p53 locus initiates biliary-mediated liver regeneration. NPJ Regen Med 2022; 7 (01) 21
    CrossrefPubMedGoogle Scholar
  • 100 He J, Chen J, Wei X. et al. Mammalian target of rapamycin complex 1 signaling is required for the dedifferentiation from biliary cell to bipotential progenitor cell in zebrafish liver regeneration. Hepatology 2019; 70 (06) 2092-2106
    CrossrefPubMedGoogle Scholar
  • 101 Zhang J, Zhou Y, Li S. et al. Tel2 regulates redifferentiation of bipotential progenitor cells via Hhex during zebrafish liver regeneration. Cell Rep 2022; 39 (01) 110596
    CrossrefPubMedGoogle Scholar
  • 102 Khaliq M, Ko S, Liu Y. et al. Stat3 regulates liver progenitor cell-driven liver regeneration in zebrafish. Gene Expr 2018; 18 (03) 157-170
    CrossrefPubMedGoogle Scholar
  • 103 Jung K, Kim M, So J, Lee SH, Ko S, Shin D. Farnesoid X receptor activation impairs liver progenitor cell-mediated liver regeneration via the PTEN-PI3K-AKT-mTOR axis in zebrafish. Hepatology 2021; 74 (01) 397-410
    CrossrefPubMedGoogle Scholar
  • 104 Miyoshi T, Hidaka M, Miyamoto D. et al. Successful induction of human chemically induced liver progenitors with small molecules from damaged liver. J Gastroenterol 2022; 57 (06) 441-452
    CrossrefPubMedGoogle Scholar
  • 105 Choi TY, Khaliq M, Tsurusaki S. et al. Bone morphogenetic protein signaling governs biliary-driven liver regeneration in zebrafish through tbx2b and id2a. Hepatology 2017; 66 (05) 1616-1630
    CrossrefPubMedGoogle Scholar
  • 106 Ko S, Russell JO, Tian J. et al. Hdac1 regulates differentiation of bipotent liver progenitor cells during regeneration via Sox9b and Cdk8. Gastroenterology 2019; 156 (01) 187-202 .e14
    CrossrefPubMedGoogle Scholar
  • 107 Cai P, Mao X, Zhao J. et al. Farnesoid X receptor is required for the redifferentiation of bipotential progenitor cells during biliary-mediated zebrafish liver regeneration. Hepatology 2021; 74 (06) 3345-3361
    CrossrefPubMedGoogle Scholar
  • 108 So J, Kim M, Lee SH. et al. Attenuating the epidermal growth factor receptor-extracellular signal-regulated kinase-sex-determining region Y-box 9 axis promotes liver progenitor cell-mediated liver regeneration in zebrafish. Hepatology 2021; 73 (04) 1494-1508
    CrossrefPubMedGoogle Scholar
  • 109 Michalopoulos GK, Barua L, Bowen WC. Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury. Hepatology 2005; 41 (03) 535-544
    CrossrefPubMedGoogle Scholar
  • 110 Limaye PB, Bowen WC, Orr AV, Luo J, Tseng GC, Michalopoulos GK. Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium. Hepatology 2008; 47 (05) 1702-1713
    CrossrefPubMedGoogle Scholar
  • 111 Limaye PB, Bowen WC, Orr A, Apte UM, Michalopoulos GK. Expression of hepatocytic- and biliary-specific transcription factors in regenerating bile ducts during hepatocyte-to-biliary epithelial cell transdifferentiation. Comp Hepatol 2010; 9: 9
    CrossrefPubMedGoogle Scholar
  • 112 Nagahama Y, Sone M, Chen X. et al. Contributions of hepatocytes and bile ductular cells in ductular reactions and remodeling of the biliary system after chronic liver injury. Am J Pathol 2014; 184 (11) 3001-3012
    CrossrefPubMedGoogle Scholar
  • 113 Yanger K, Zong Y, Maggs LR. et al. Robust cellular reprogramming occurs spontaneously during liver regeneration. Genes Dev 2013; 27 (07) 719-724
    CrossrefPubMedGoogle Scholar
  • 114 Sekiya S, Suzuki A. Hepatocytes, rather than cholangiocytes, can be the major source of primitive ductules in the chronically injured mouse liver. Am J Pathol 2014; 184 (05) 1468-1478
    CrossrefPubMedGoogle Scholar
  • 115 Lorent K, Moore JC, Siekmann AF, Lawson N, Pack M. Reiterative use of the notch signal during zebrafish intrahepatic biliary development. Dev Dyn 2010; 239 (03) 855-864
    CrossrefPubMedGoogle Scholar
  • 116 Zong Y, Panikkar A, Xu J. et al. Notch signaling controls liver development by regulating biliary differentiation. Development 2009; 136 (10) 1727-1739
    CrossrefPubMedGoogle Scholar
  • 117 Lemaigre FP. Development of the intrahepatic and extrahepatic biliary tract: a framework for understanding congenital diseases. Annu Rev Pathol 2020; 15: 1-22
    CrossrefPubMedGoogle Scholar
  • 118 Hu S, Molina L, Tao J. et al. NOTCH-YAP1/TEAD-DNMT1 axis drives hepatocyte reprogramming into intrahepatic cholangiocarcinoma. Gastroenterology 2022; 163 (02) 449-465
    CrossrefPubMedGoogle Scholar
  • 119 Fan B, Malato Y, Calvisi DF. et al. Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest 2012; 122 (08) 2911-2915
    CrossrefPubMedGoogle Scholar
  • 120 Molina L, Nejak-Bowen K, Monga SP. Role of YAP1 signaling in biliary development, repair, and disease. Semin Liver Dis 2022; 42 (01) 17-33
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 121 Lee DH, Park JO, Kim TS. et al. LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development. Nat Commun 2016; 7: 11961
    CrossrefPubMedGoogle Scholar
  • 122 Planas-Paz L, Sun T, Pikiolek M. et al. YAP, but not RSPO-LGR4/5, signaling in biliary epithelial cells promotes a ductular reaction in response to liver injury. Cell Stem Cell 2019; 25 (01) 39-53 .e10
    CrossrefPubMedGoogle Scholar
  • 123 Li W, Yang L, He Q. et al. A homeostatic Arid1a-dependent permissive chromatin state licenses hepatocyte responsiveness to liver-injury-associated YAP signaling. Cell Stem Cell 2019; 25 (01) 54-68 .e5
    CrossrefPubMedGoogle Scholar
  • 124 Liu Y, Zhuo S, Zhou Y. et al. Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis. J Hepatol 2022; 76 (03) 652-664
    CrossrefPubMedGoogle Scholar
  • 125 Wang J, Dong M, Xu Z. et al. Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice. Oncogene 2018; 37 (24) 3229-3242
    CrossrefPubMedGoogle Scholar
  • 126 Yimlamai D, Christodoulou C, Galli GG. et al. Hippo pathway activity influences liver cell fate. Cell 2014; 157 (06) 1324-1338
    CrossrefPubMedGoogle Scholar
  • 127 Schaub JR, Huppert KA, Kurial SNT. et al. De novo formation of the biliary system by TGFβ-mediated hepatocyte transdifferentiation. Nature 2018; 557 (7704): 247-251
    CrossrefPubMedGoogle Scholar
  • 128 Tschaharganeh DF, Xue W, Calvisi DF. et al. p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer. Cell 2014; 158 (03) 579-592
    CrossrefPubMedGoogle Scholar
  • 129 Jeliazkova P, Jörs S, Lee M. et al. Canonical Notch2 signaling determines biliary cell fates of embryonic hepatoblasts and adult hepatocytes independent of Hes1. Hepatology 2013; 57 (06) 2469-2479
    CrossrefPubMedGoogle Scholar
  • 130 Guo J, Fu W, Xiang M. et al. Notch1 drives the formation and proliferation of intrahepatic cholangiocarcinoma. Curr Med Sci 2019; 39 (06) 929-937
    CrossrefPubMedGoogle Scholar
  • 131 Pham DH, Kudira R, Xu L. et al. Deleterious variants in ABCC12 are detected in idiopathic chronic cholestasis and cause intrahepatic bile duct loss in model organisms. Gastroenterology 2021; 161 (01) 287-300 .e16
    CrossrefPubMedGoogle Scholar
  • 132 Lee SH, So J, Shin D. Hepatocyte-to-cholangiocyte conversion occurs through transdifferentiation independently of proliferation in zebrafish. Hepatology 2023, in press
    PubMedGoogle Scholar
  • 133 Russell JO, Ko S, Monga SP, Shin D. Notch inhibition promotes differentiation of liver progenitor cells into hepatocytes via sox9b repression in zebrafish. Stem Cells Int 2019; 2019: 8451282
    CrossrefPubMedGoogle Scholar
  • 134 Everton E, Rizvi F, Smith AR. et al. Transient yet robust expression of proteins in the mouse liver via intravenous injection of lipid nanoparticle-encapsulated nucleoside-modified mRNA. Bio Protoc 2021; 11 (19) e4184
    CrossrefPubMedGoogle Scholar
  • 135 Pepe-Mooney BJ, Dill MT, Alemany A. et al. Single-cell analysis of the liver epithelium reveals dynamic heterogeneity and an essential role for YAP in homeostasis and regeneration. Cell Stem Cell 2019; 25 (01) 23-38 .e8
    CrossrefPubMedGoogle Scholar
  • 136 Bou Saleh M, Louvet A, Ntandja-Wandji LC. et al. Loss of hepatocyte identity following aberrant YAP activation: a key mechanism in alcoholic hepatitis. J Hepatol 2021; 75 (04) 912-923
    CrossrefPubMedGoogle Scholar
  • 137 Glaser SS, Gaudio E, Miller T, Alvaro D, Alpini G. Cholangiocyte proliferation and liver fibrosis. Expert Rev Mol Med 2009; 11: e7
    CrossrefPubMedGoogle Scholar
  • 138 Kaur S, Siddiqui H, Bhat MH. Hepatic progenitor cells in action: liver regeneration or fibrosis?. Am J Pathol 2015; 185 (09) 2342-2350
    CrossrefPubMedGoogle Scholar
  • 139 Katoonizadeh A, Nevens F, Verslype C, Pirenne J, Roskams T. Liver regeneration in acute severe liver impairment: a clinicopathological correlation study. Liver Int 2006; 26 (10) 1225-1233
    CrossrefPubMedGoogle Scholar
  • 140 Rodrigo-Torres D, Affò S, Coll M. et al. The biliary epithelium gives rise to liver progenitor cells. Hepatology 2014; 60 (04) 1367-1377
    CrossrefPubMedGoogle Scholar
  • 141 Furuyama K, Kawaguchi Y, Akiyama H. et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 2011; 43 (01) 34-41
    CrossrefPubMedGoogle Scholar
  • 142 Font-Burgada J, Shalapour S, Ramaswamy S. et al. Hybrid periportal hepatocytes regenerate the injured liver without giving rise to cancer. Cell 2015; 162 (04) 766-779
    CrossrefPubMedGoogle Scholar
  • 143 Lesaffer B, Verboven E, Van Huffel L. et al. Comparison of the Opn-CreER and Ck19-CreER drivers in bile ducts of normal and injured mouse livers. Cells 2019; 8 (04) 8
    CrossrefPubMedGoogle Scholar
  • 144 Morales-Ibanez O, Domínguez M, Ki SH. et al. Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis. Hepatology 2013; 58 (05) 1742-1756
    CrossrefPubMedGoogle Scholar
  • 145 Uede T. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases. Pathol Int 2011; 61 (05) 265-280
    CrossrefPubMedGoogle Scholar
  • 146 Zweerink S, Mueck V, Kraemer LP. et al. Repolarization precedes oval cell-mediated hepatocytic regeneration in the CDE diet mouse model. J Histochem Cytochem 2022; 70 (05) 377-389
    CrossrefPubMedGoogle Scholar
  • 147 Sekiya S, Suzuki A. Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes. J Clin Invest 2012; 122 (11) 3914-3918
    CrossrefPubMedGoogle Scholar
  • 148 Yoshii D, Shimata K, Yokouchi Y. et al. SOX9 contributes to the progression of ductular reaction for the protection from chronic liver injury. Hum Cell 2022; 35 (02) 721-734
    CrossrefPubMedGoogle Scholar